Global or local? COVID-19 has highlighted the need to update the pharma supply chain. From manufacturing to distribution of medicines, the global supply chain has enabled the industry to reach economies of scale and make essential drugs available and affordable for many patients.
However, it’s also made it vulnerable to bottlenecks such as the complex tangle of systems and processes across different countries creating a domino effect that delays production and exacerbated by the pandemic as the demand outruns the supply.
As the dust is still settling from the pandemic, stakeholders across the ecosystem are looking to re-strategize and work more closely together to build new strengths in the supply chain to tackle this among other emerging and permanent shifts in healthcare.
With a local and regional focus on Singapore and Asia-Pacific, the 8th Annual PharmaCon Asia will look at rewriting pharma’s rules and collaborating for a sustainable future. The event will bring together bring together pharma manufacturers, the biotech/startup-VC ecosystem, technology and service providers, and government stakeholders of every level to address current trends and prospects shaping the future of the industry.
THIS IS A FORUM DESIGNED TO CONVENE KEY DECISION-MAKERS IN PHARMA. CO-LOCATING:
